完全腹腔镜根治术治疗胆囊癌患者安全性及疗效临床分析*

doi:10.3969/j.issn.1672-5069.2018.04.011

摘要/Abstract

摘要： 目的探讨完全腹腔镜胆囊癌根治术（LRC）治疗胆囊癌患者的安全性及疗效。方法 2013年1月~2015年12月我院收治的40例胆囊癌患者,其中19例接受LRC治疗,21例接受开腹胆囊癌根治术。随访2年,采用Kaplan-Meier生存曲线行生存分析。结果 LRC组手术时间、淋巴结清扫数和术中出血量分别为（238.4±31.2）min、（7.5±1.2）个和（210.5±21.1） ml,而开腹组分别为（316.5±11.5） min、（7.8±0.9）个和（301.2±22.8 ）ml,其中手术时间和出血量显著短于或少于开腹组（P<0.01）;下床活动时间、拔管时间、进食时间、肛门排气时间和住院日分别为（2.1±0.5） d、（3.5±2.1） d、（2.5±0.9） d、（1.1±0.1） d和（5.4±2.1） d,均显著短于开腹组【分别为（7.1±1.2） d、（14.5±6.6） d、（3.8±1.8） d、（1.9±0.5） d和（8.2±5.8） d,P<0.01】;LRC组发生切口感染1例,胆漏2例（15.8 %）,而开腹组发生切口感染4例,胆漏5例（42.9%,x²=4.286,P=0.038）;LRC组和开腹组1 a生存率分别为94.7%和95.2%,2 a生存率为78.9 %和71.4 %,两组总体生存率比较无统计学差异（x²=0.655,P=0.418）;术后第13个月和18个月,LRC组各有1例出现腹腔淋巴结转移,术后第14个月、16个月和20个月,开腹组各有1例出现腹腔淋巴结转移。结论 LRC治疗胆囊癌患者安全可行,疗效与开放性胆囊癌根治术相同,但手术时间和住院时间更短。

关键词: 胆囊癌, 腹腔镜, 根治性切除术, 疗效

Abstract: Objective To investigate the safety and efficacy of laparoscopic radical cholecystectomy (LRC) in treatment of patients with gallbladder cancer. Methods 40 patients with gallbladder cancer were recruited in our hospital between January 2013 and December 2015,and were randomly divided into two groups. 19 received LRC,and 21 received open radical cholecystectomy. All patients were followed-up for two years,and the overall survival was estimated by Kaplan-Meier analysis. Results The operation time,the numbers of lymph nodes cleared and bleeding in the LRC group were（238.4±31.2）min,（7.5±1.2） and（210.5±21.1）ml,while they were [（316.5±11.5）min（P<0.01),（7.8±0.9） and（301.2±22.8）ml（P<0.01),in the open redical cholecystectomy, respectively];the ambulation time,stoping drainage time,eating time,postoperative exhaust time and hospitalization time were（2.1±0.5）d,（3.5±2.1）d,（2.5±0.9）d,（1.1±0.1）d and （5.4±2.1）d,much shorter than in the open redical cholecystectomy [（7.1±1.2）d,（14.5±6.6）d,（3.8±1.8）d,（1.9±0.5）d and （8.2±5.8）d,respectively,P<0.01】;infection and bile leak occurred in one and two patients （15.8 %） in LRC group,much lower than four and five（42.9%,x²=4.286,P=0.038） in the open redical cholecystectomy;the 1 year survival rates in LRC and in open redical cholecystectomy group were 94.7% and 95.2%,and 2 year survival rates were 78.9 % and 71.4 %,respectively in the two groups（x²=0.655,P=0.418）;abdominal lymph node metastasis occurred in two patients in LRC group and in three in patients underwent open redical cholecystectomy. Conclusion LRC is safe and feasible for the treatment of patients with gallbladder cancer, and the efficacy is similar to that,but hospitalization time is shorter than that with open radical cholecystectomy.

Key words: Gallbladder cancer, Laparoscopy, Radical resection, Efficacy

张德智, 刘现立, 赵玉鹏. 完全腹腔镜根治术治疗胆囊癌患者安全性及疗效临床分析^*[J]. 实用肝脏病杂志, 2018, 21(4): 529-532.

Zhang Dezhi, Liu Xianli, Zhao Yupeng. Clinical efficacy and safety of laparoscopic radical cholecystectomy in treatment of patients with gallbladder cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 529-532.

参考文献

[1] Hundal R,Shaffer EA.Gallbladder cancer:epidemiology and outcome. Clin Epidemiol,2014,6(1):99-109.
[2] Li YP,Wang SN,Lee KT.Robotic versus conventional laparoscopic cholecystectomy:A comparative study of medical resource utilization and clinical outcomes.Kaohsiung J Med Sci,2017,33(4):201-206.
[3] 王锦,崔永红. 腹腔镜胆囊癌根治术的适应证及临床价值分析. 中国药物经济学,2014,10(1):257-258.
[4] 马骖. 26例原发胆囊癌临床分析. 实用肝脏病杂志,2003,6(3):160-161.
[5] Sharma A,Sharma KL,Gupta A,et al.Gallbladder cancer epidemiology,pathogenesis and molecular genetics:Recent update.World J Gastroenterol,2017,23(22):3978-3998.
[6] Berger-Richardson D,Chesney TR,Englesakis M,et al.Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer:A systematic review. Surgery,2017,161(3): 618-627.
[7] Yeh CN,Jan YY,Chen MF.Management of unsuspected gallbladder carcinoma discovered during or following laparoscopic cholecystectomy. Am Surg,2004,70(3):256-258.
[8] Canis M,Botchorishvili R,Wattiez A,et al.Cancer and laparoscopy,experimental studies:a review. Eur J Obstet Gynecol Reprod Biol,2000,91(1):1-9.
[9] Shirobe T,Maruyama S.Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma. Surg Endosc, 2015,29(8):2244-2250.
[10] Machado MA,Makdissi FF,Surjan RC.Totally laparoscopic hepatic bisegmentectomy (s4b+s5) and hilar lymphadenectomy for incidental gallbladder cancer.Ann Surg Oncol,2015,22(3):1-4.
[11] Itano O,Oshima G,Minagawa T,et al.Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc,2015,29(12):3600-3607.
[12] Fornara P,Zacharias M,Wagner S.Port-site metastases:Fact or fiction?Urol Int,2003,71(2):136-142.
[13] 黄长文,李师淼,花京文,等. 全腹腔镜胆囊癌根治术:初步经验与思考. 中华腔镜外科杂志:电子版,2015,5(5):367-369.
[14] Whalen GF,Bird I,Tanski W,et al.Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg,2017,192(2):189-195.
[15] Antonakis P,Alexakis N,Mylonaki D,et al.Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy. Eur J Surg Oncol,2003,29(4):358-360.
[16] Utsumi M,Aoki H, Kunitomo T,et al.Evaluation of surgical treatment for incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy:single center results.BMC Res Notes,2017,10(1):56-60.
[17] Su W L,Huang J W,Wang S N,et al.Comparison study of clinical outcomes between single-site robotic cholecystectomy and single incision laparoscopic cholecystectomy. Asian J Surg,2016,40(6):424-428.
[18] Nucci T,Guernelli NA,Valle D,et al.Quality of life and cancer. Appl Cancer Res,2006,26(2):1-7.
[19] Vega EA,Yamashita S,Yun SC,et al.Effective laparoscopic management lymph node dissection for gallbladder cancer. Ann Surg Oncol,2017,24(7):1-7.
[20] Ouchi K,Mikuni J,Kakugawa Y.Laparoscopic cholecystectomy for gallbladder carcinoma:results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg,2002,9(2):256-260.

完全腹腔镜根治术治疗胆囊癌患者安全性及疗效临床分析^*

Clinical efficacy and safety of laparoscopic radical cholecystectomy in treatment of patients with gallbladder cancer

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[2]	张燕妮, 孙晓花, 何海燕, 杜芸芸, 韩慧. 腔镜肝门肠吻合术治疗新生儿胆道闭锁症疗效初步研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 920-923.
[3]	巴正武, 栗海龙, 杨慧. 能谱CT成像定量评估Budd-Chiari综合征患者TIPS术治疗前后肝功能状态临床价值研究*[J]. 实用肝脏病杂志, 2019, 22(5): 680-683.
[4]	张志成, 袁广庆, 莫灿均. 肝动脉栓塞术治疗三种类型肝血管瘤患者疗效及安全性分析*[J]. 实用肝脏病杂志, 2019, 22(5): 736-739.
[5]	白一春, 邓霁红, 梅小平. 影响聚乙二醇干扰素α-2b治疗慢性乙型肝炎患者疗效的多因素分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 490-493.
[6]	严玲玲, 胡东辉, 黄艳芳. 腺苷蛋氨酸联合多烯磷酯酰胆碱治疗妊娠期肝内胆汁淤积症患者临床疗效初步研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 530-533.
[7]	刘文博, 张建业, 保积武, 刘震. 吲哚菁绿介导的近红外光检测技术在胆囊癌手术切除术中的应用^*[J]. 实用肝脏病杂志, 2019, 22(4): 573-576.
[8]	祁莉娜, 颜梅, 郭建琴. 腹腔镜下肝囊肿开窗术与超声引导下穿刺介入治疗单纯性肝囊肿患者疗效对比研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 581-584.
[9]	王宝丹, 李萌, 高于. α-干扰素治疗慢性乙型肝炎儿童疗效及其影响疗效的因素分析[J]. 实用肝脏病杂志, 2019, 22(3): 345-348.
[10]	袁春晖, 李春雨, 李红丽, 赵红娜, 王文红, 孟庆旭, 张中学. 国产聚乙二醇化干扰素α治疗HBeAg阳性慢性乙型肝炎患者疗效研究[J]. 实用肝脏病杂志, 2019, 22(3): 353-356.
[11]	徐曼曼, 陈煜, 李爽. 特利加压素联合白蛋白输注治疗肝肾综合征患者疗效及尿NGAL和KIM-1对疗效的预测价值[J]. 实用肝脏病杂志, 2019, 22(3): 385-388.
[12]	田宋君, 李伟学, 李中明, 昌红斌, 詹争明, 江铃. 腹腔镜手术联合肝动脉栓塞治疗外伤性肝破裂患者临床疗效及影响预后因素分析[J]. 实用肝脏病杂志, 2019, 22(3): 429-432.
[13]	王运成, 潘正故, 翟刚, 岑川. B超引导下经皮穿刺胆道造瘘气压弹道碎石取石治疗肝内外胆管结石患者疗效分析[J]. 实用肝脏病杂志, 2019, 22(3): 441-444.
[14]	王秀清,马艳君,詹晋莉. 肝动脉化疗栓塞术联合超声引导下微波消融术治疗特殊部位原发性肝癌患者疗效及安全性分析 ^*[J]. 实用肝脏病杂志, 2019, 22(2): 260-263.
[15]	赵鹏, 王磊. 聚乙二醇化干扰素-α对不同基因型慢性丙型肝炎患者治疗效果比较^*[J]. 实用肝脏病杂志, 2019, 22(1): 57-60.